dedifferentiated liposarcomaDDLPSpalbociclibMemorial Sloan Kettering Cancer Centerretifanlimab
… 6 (CDK4/6) inhibitor palbociclib delays disease progression in dedifferentiated liposarcoma (DDLPS) by inducing tumor cell quiescence or senescence, though…